7.45
-0.45
(-5.70%)
At close: January 30 at 11:24:22 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 3 | 5 | 6 |
| Avg. Estimate | 17.07M | 5.07M | 113.15M | 72.54M |
| Low Estimate | 200k | -- | 96.39M | -- |
| High Estimate | 40.19M | 15M | 136.38M | 155M |
| Year Ago Sales | 4.25M | 27.36M | 8.57M | 113.15M |
| Sales Growth (year/est) | 301.34% | -81.48% | 1,219.87% | -35.89% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AT20.F | -- | -- | -- | -- |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 1/22/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 1/17/2025 |
| Initiated | Rodman & Renshaw: Buy | 12/20/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 11/13/2024 |
| Reiterates | HC Wainwright & Co.: Neutral | 8/21/2024 |
| Upgrade | Mizuho: Neutral to Outperform | 8/16/2024 |
Related Tickers
8AW0.BE Ocean Biomedical Inc
0.1810
-23.31%
0M4.DU Mersana Therapeutics Inc
0.5906
+2.64%
8AW0.F Ocean Biomedical, Inc.
0.2200
-34.91%
M55.F MacroGenics, Inc.
2.8940
-5.67%
2UV.F Applied Therapeutics, Inc.
0.5150
-2.00%
2UV.DU Applied Therapeutics Inc
0.5745
+2.96%
NV4.F Cellectar Biosciences, Inc.
0.2000
-9.91%
1VT.DU Viking Therapeutics Inc
32.15
-1.20%
3G0.BE Altimmune Inc
6.71
-0.52%
NV4.MU Cellectar Biosciences Inc
0.2420
-3.20%